CM Hospitalar SA
BOVESPA:VVEO3

Watchlist Manager
CM Hospitalar SA Logo
CM Hospitalar SA
BOVESPA:VVEO3
Watchlist
Price: 1.31 BRL -0.76% Market Closed
Market Cap: 422.9m BRL

Wall Street
Price Targets

VVEO3 Price Targets Summary
CM Hospitalar SA

Wall Street analysts forecast VVEO3 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for VVEO3 is 1.56 BRL with a low forecast of 1.01 BRL and a high forecast of 2.1 BRL.

Lowest
Price Target
1.01 BRL
23% Downside
Average
Price Target
1.56 BRL
19% Upside
Highest
Price Target
2.1 BRL
60% Upside
CM Hospitalar SA Competitors:
Price Targets
600511
China National Medicines Corp Ltd
31% Upside
PHARMA
Pharmaniaga Bhd
17% Downside
GALE
Galenica AG
11% Downside
0HF3
Amerisourcebergen Corp
14% Upside
ILM1
Medios AG
60% Upside
CAH
Cardinal Health Inc
5% Upside
SIG
Sigma Healthcare Ltd
19% Upside

Revenue
Forecast

Revenue Estimate
CM Hospitalar SA

For the last 5 years the compound annual growth rate for CM Hospitalar SA's revenue is 31%. The projected CAGR for the next 4 years is 5%.

31%
Past Growth
5%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Operating Income
Forecast

Operating Income Estimate
CM Hospitalar SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-14%
Average Miss

Net Income
Forecast

Net Income Estimate
CM Hospitalar SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
26%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is VVEO3's stock price target?
Price Target
1.56 BRL

According to Wall Street analysts, the average 1-year price target for VVEO3 is 1.56 BRL with a low forecast of 1.01 BRL and a high forecast of 2.1 BRL.

What is CM Hospitalar SA's Revenue forecast?
Projected CAGR
5%

For the last 5 years the compound annual growth rate for CM Hospitalar SA's revenue is 31%. The projected CAGR for the next 4 years is 5%.

Back to Top